Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)

Armando Santoro, MD

Status: Completed

Conditions: Non Small Cell Lung Cancer

Treatments: Genetic: Protein expression by immunohistochemistry and immunofluorescence

Study type: Observational

Funder types: Other

Identifiers

NCT00763607

ONC/OSS-02/2007

Details and patient eligibility

About

Aim of the study is to evaluated the role of IGF1R and p95HER2 on prognosis in radically resected non small cell lung cancer patients

The primary objective is to correlate the expression of IGF1R and p95HER2 with survival.

Enrollment: 454 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Radically resected non small cell lung cancer patients with tumor tissue available

Exclusion criteria

• Tumor tissue not available
• Clinical data not available

Trial design

454 participants in 1 patient group

1

Description:

Radically resected Non small cell lung cancer patients in stage I-III

Treatment:

Genetic: Protein expression by immunohistochemistry and immunofluorescence